Page 174 - Memoria SEHH 2022
P. 174

   MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GETCC
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
    Comunicaciones orales
Congresos internacionales
• Preparation and clinical evaluation of eye drops from cord blood platelet lysate. First Eye Drops of Human Origin (EDHO) Workshop on Current Standard and Future Developments. Viena, 11-13 de mayo de 2022.
Paolo Rebulla, Dinara Samarkanova, Sergio Querol .
• Preservation of critical quality attributes in 3D bioprinted cell-based structures by using natural hydrogels.
27th European Society for Animal Cell Technology (ESACT) Meeting 2022. Lisboa, 26-29 de junio de 2022.
Vives J, Martorell L, López-Fernández A, García-Lizarribar A, Sabata R, Gálvez-Martín P, Samitier J .
• Success in the Treatment of Challenging Cases with Umbilical Cord Eye Drops.
40th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) 2022. Milán, 16-20 de septiembre de 2022.
Martín Nalda S, Bisbe López L, Puig Galy JJ, Pueyo Ferrer A, Oliver Gutiérrez D, Ros Sánchez E, Samarkanova D; Programa Concordia-BST (Barcelona Cord Blood Bank) .
• A phase 1, first-in-human, dose-escalation clinical trial of memory-enriched CD30- CAR-T-cell therapy for the treatment of relapsed or refractory Hodgkin lymphoma and CD30+ T-cell lymphoma.
European Hematology Association (EHA) 2022 Congress. Viena, 9 al 12 de junio de 2022. Caballero AC, Escribà-García L, Montserrat-Torres R, Escudero-López E, Pujol-Fernández P, Ujal- dón-Miró C, García-Cadenas I, Esquirol A, Martino R, Sierra J, Álvarez-Fernández C, Briones J .
• Phase 1 Clinical Trial of Memory-Enriched Academic HSP-CAR30 for the Treatment of Relapsed/Refractory Hodgkin Lymphoma and CD30+ T-Cell Lymphoma: Clinical and Biological Studies.
64th American Society of Hematology (ASH) Annual Meeting and Exposition. New Orleans (USA), 10-13 de diciembre de 2022.
Caballero AC, Escribà-García L, Montserrat-Torres R, Escudero-López E, Pujol-Fernández P, Ujal- dón-Miró C, García-Cadenas I, Esquirol A, Martino R, Sierra J, Álvarez-Fernández C, Briones J .
  174
 














































































   172   173   174   175   176